Use of oritavancin for prevention and treatment of anthrax

Details Use of oritavancin for prevention and treatment of anthrax Use of oritavancin for prevention and treatment of anthrax

A - Human Necessities

61

K

A61K 31/7052 (2006.01) A61K 31/00 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2664444

Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against B. anthracis. Methods for the treatment, prophylaxis and prevention of B. anthracis infection and disease in animals, including humans, are described.

L'invention concerne des antibiotiques glycopeptidiques, tels que de l'oritavancine, qui présentent une activité significative contre le B. anthracis (Bacille du charbon). L'invention concerne également des procédés de traitement, de prophylaxie et de prévention d'une infection par le B. anthracis et d'une maladie chez les animaux, y compris les êtres humains.

Affiliated with

Also associated with

Rating

Use of oritavancin for prevention and treatment of anthrax does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of oritavancin for prevention and treatment of anthrax, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of oritavancin for prevention and treatment of anthrax will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2064105